ERS International Congress 2023 - Poster session Viral infections and antibiotic use

Airway diseases

Poster session

Viral infections and antibiotic use Clinical

Methods : Endoscopy and interventional pulmonology, Respiratory intensive care, Cell and molecular biology, Public health, General respiratory patient care, Epidemiology

Chairs

Agia Paraskeyi (Greece)

London (United Kingdom)

RSV as a Cause of Exacerbations of COPD D. Wiseman(London, United Kingdom)

Disruption in typical patterns of seasonality of respiratory viral infections (RVIs) M. Purcell(Southampton, United Kingdom)

A novel rhinovirus mRNA vaccine induces humoral and cellular immunity, providing protection against heterotypic rhinovirus infection C. Pyle(London, United Kingdom)

LSC - 2023 - Iron metabolism determines the outcome of influenza A virus infection

Estimated incidence of hospitalizations and primary care visits attributable to RSV infections in adults in Germany between 2015 – 2019 L. Bayer(Berlin, Germany)

Association between clinical presentation and a host transcriptomic signature in patients with lower respiratory tract infection undergoing bronchoscopy A. Hoheisel(Leipzig, Germany)

Characterisation of clinical risk factors for severity and outcome in adults hospitalised with respiratory viral infection (RVI): the UNIVERSAL study. T. Morelli(Southampton, United Kingdom)

Changes in the epidemiology of severe acute respiratory virus infection in the elderly after social distancing was lifted J. Shim(Seoul, Republic of Korea)

INNA-051 pre-exposure prophylaxis in a human influenza infection model R. Tal-Singer(Media, United States)

Real-world primary care data of antibiotic prescriptions for sore throat in Italy G. Coutinho(London, United Kingdom)

Medical practices that create risks for the development of antibacterial resistance I. Liverko(Tashkent, Uzbekistan)

Savings potential for antibiotics in respiratory infections: Insights from the European market P. Kardos(Frankfurt am Main, Germany)

Inflammatory and mucociliary dysfunction based endotypes across the spectrum of chronic airways diseases E. Cant(Dundee, United Kingdom)

Respiratory infection with multidrug resistant organisms is more often in men than women- a retrospective, multicenter study C. Kodde(Berlin, Germany)

Predictive factors for a good pulmonary penetration of antibiotics: AntiBiotics dosage in BronchoAlveolar Lavage J. Delomez(Neuvillette, France)

Detection of respiratory viruses in patients with aspiration pneumonia: a retrospective study D. Nabeya(Okinawa, Japan)

Aftershocks caused by viruses A. Sárközi(Debrecen, Hungary)

Findings from a new 12-country survey of respiratory illness, symptoms, and management approaches G. Coutinho(London, United Kingdom)

Risk factors for influenza-induced exacerbations and mortality in non-cystic fibrosis bronchiectasis H. Huang(Taipei, Taiwan)

Late Breaking Abstract - Remdesivir reduces progression to ICU in patients hospitalized with COVID-19 R. Shah Gupta(Foster City, United States)